MITOMYCIN and RASH

Overview

RASH is the #8 most commonly reported adverse reaction for MITOMYCIN, manufactured by UroGen Pharma, Inc.. There are 104 FDA adverse event reports linking MITOMYCIN to RASH. This represents approximately 2.3% of all 4,566 adverse event reports for this drug.

Patients taking MITOMYCIN who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for MITOMYCIN, but still significant enough to appear in the safety profile.

Other Side Effects of MITOMYCIN

In addition to rash, the following adverse reactions have been reported for MITOMYCIN:

• OFF LABEL USE — 372 reports
• NAUSEA — 159 reports
• DIARRHOEA — 146 reports
• FATIGUE — 116 reports
• THROMBOCYTOPENIA — 108 reports
• DRUG INEFFECTIVE — 106 reports
• NEUTROPENIA — 105 reports
• VOMITING — 104 reports
• PANCYTOPENIA — 100 reports
• DISEASE PROGRESSION — 95 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does MITOMYCIN cause RASH?

RASH has been reported as an adverse event in 104 FDA reports for MITOMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with MITOMYCIN?

RASH accounts for approximately 2.3% of all adverse event reports for MITOMYCIN, making it a notable side effect.

What should I do if I experience RASH while taking MITOMYCIN?

If you experience rash while taking MITOMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages